ATE264840T1 - Azetidincarboxamid-derivate zur behandlung von zns störungen - Google Patents

Azetidincarboxamid-derivate zur behandlung von zns störungen

Info

Publication number
ATE264840T1
ATE264840T1 AT99901782T AT99901782T ATE264840T1 AT E264840 T1 ATE264840 T1 AT E264840T1 AT 99901782 T AT99901782 T AT 99901782T AT 99901782 T AT99901782 T AT 99901782T AT E264840 T1 ATE264840 T1 AT E264840T1
Authority
AT
Austria
Prior art keywords
cns disorders
treatment
carboxamide derivatives
azetidine carboxamide
azetidine
Prior art date
Application number
AT99901782T
Other languages
English (en)
Inventor
David Reginald Adams
Ian Anthony Cliffe
Howard Langham Mansell
Nathaniel Julius Monck
Original Assignee
Vernalis Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vernalis Res Ltd filed Critical Vernalis Res Ltd
Application granted granted Critical
Publication of ATE264840T1 publication Critical patent/ATE264840T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99901782T 1998-01-23 1999-01-22 Azetidincarboxamid-derivate zur behandlung von zns störungen ATE264840T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9801501.9A GB9801501D0 (en) 1998-01-23 1998-01-23 Chemical compounds - II
PCT/GB1999/000224 WO1999037614A1 (en) 1998-01-23 1999-01-22 Azetidinecarboxamide derivatives for the treatment of cns disorders

Publications (1)

Publication Number Publication Date
ATE264840T1 true ATE264840T1 (de) 2004-05-15

Family

ID=10825809

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99901782T ATE264840T1 (de) 1998-01-23 1999-01-22 Azetidincarboxamid-derivate zur behandlung von zns störungen

Country Status (8)

Country Link
US (1) US6514961B1 (de)
EP (1) EP1049671B1 (de)
JP (1) JP2002501047A (de)
AT (1) ATE264840T1 (de)
AU (1) AU2178199A (de)
DE (1) DE69916577D1 (de)
GB (1) GB9801501D0 (de)
WO (1) WO1999037614A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9917385D0 (en) * 1999-07-23 1999-09-22 Cerebrus Ltd Chemical compounds-I
GB9917386D0 (en) * 1999-07-23 1999-09-22 Cerebrus Ltd Chemical compounds-II
EP2265578B1 (de) * 2008-03-04 2015-09-16 Vernalis (R&D) Ltd. Azetidinderivate
JOP20190072A1 (ar) * 2016-10-13 2019-04-07 Glaxosmithkline Ip Dev Ltd مشتقات 1، 3 سيكلوبوتان ثنائي الاستبدال أو آزيتيدين كمثبطات للإنزيم المخلق للبروستاجلاندين d المكون للدم

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226861A (en) * 1978-04-18 1980-10-07 A. H. Robins Company, Inc. N-Lower-alkyl 3-phenoxy-1-azetidinecarboxamides
US4505907A (en) * 1982-09-02 1985-03-19 A. H. Robins Company, Inc. N-Formyl and N-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides
FI87559C (fi) * 1985-02-28 1993-01-25 Robins Co Inc A H Foerfarande foer framstaellning av aktiva 3-fenyloxiazetidinkarboxamider
US5068231A (en) 1985-02-28 1991-11-26 A. H. Robins Company Incorporated Method of treating muscular tension, muscle spasticity and anxiety with 3-aryloxy and 3-arylthioazetidinecarboxamides
US5183903A (en) 1991-11-26 1993-02-02 A. H. Robins Company, Incorporated Urea fusion process for the synthesis of 3-phenoxy-1-azetidinecarboxamides

Also Published As

Publication number Publication date
EP1049671B1 (de) 2004-04-21
DE69916577D1 (de) 2004-05-27
GB9801501D0 (en) 1998-03-18
JP2002501047A (ja) 2002-01-15
WO1999037614A1 (en) 1999-07-29
EP1049671A1 (de) 2000-11-08
US6514961B1 (en) 2003-02-04
AU2178199A (en) 1999-08-09

Similar Documents

Publication Publication Date Title
DE69411424T2 (de) Zur Behandlung von Erkrankungen des Zentralnervensystems verwendbare Benzimidazole
ATE302751T1 (de) Verbindungen zur behandlung der alzheimerischen krankheit
SE0104332D0 (sv) Therapeutic agents
AP1852A (en) '3-Azabicyclo{3.1.0] hexane derivatives as opiate receptors ligands.
ATE272398T1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
FI914723A0 (fi) 17b-substituerade 4-aza-5a-androstan -3-jon-derivat och foerfarande foer framstaellning av desamma.
SG128491A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
DE69331171D1 (de) Chinolin und Chinazolin Derivate zur Behandlung von Arthritis
NZ334736A (en) Acylaminoalkenylene-amide derivatives useful in treatments of the respiratory diseases where it is more specific for NK1 than NK2
BG105710A (en) 5ht1 antagonists for antidepressant therapy
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ATE264840T1 (de) Azetidincarboxamid-derivate zur behandlung von zns störungen
DE69911373D1 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
DE69902142T2 (de) Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
DK0804186T3 (da) Indolditerpenalkaloidforbindelser
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
SI1603877T1 (sl) Novi derivati aminopiridina kot antagonisti mGiuR5
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
DE60000405T2 (de) 1,4-disubstitutierte cyclohexanderivate zur behandlung von depression
MY130771A (en) 3-azabicyclo [3.1.0] hexane derivatives useful in therapy.
ES2097688A1 (es) Hexahidroazepinonas y tetrahidrobenzazepinonas sustituidas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties